A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Pancreatic NeoplasmsMetastases, Neoplasm
Interventions
DRUG

GEMZAR

DRUG

ALIMTA

Trial Locations (114)

Unknown

Huntsville

Fountain Valley

Fullerton

Lancaster

Los Angeles

Pomona

Santa Rosa

Torrance

Fort Collins

Hartford

Lake Worth

Miami

Chicago

Decatur

Harvey

Indianapolis

Wichita

Crestview Hills

Louisville

Lafayette

Shreveport

Scarborough

Burlington

Omaha

Albuquerque

New York

Canton

Cleveland

Drexel Hill

Pittsburgh

Charleston

Columbia

Johnson City

Memphis

Nashville

San Antonio

Tyler

Tacoma

Marshfield

Milwaukee

Capitol Federal

Mendoza

Santa Fe

Ciudad de Buenos Aires

Bankstown

Kingswood Penrith

Wollongong

Southport

Fitzroy

Frankston

Innsbruck

Saint Veit Glan

Vienna

Brussels

Ghent

Leuven

Santiago de Cali

Strasbourg

Lille

Marseille

Paris

Rennes

Rouen

Toulouse

Bielefeld

Berlin

Bremerhaven

Frankfurt

Kaiserslautern

Karlsruhe

Magdeburg

Mannheim

München

Neustadt/Suedharz

Stuttgart

Marousi

Ioannina

Genova

Ravenna

Roma

Breda

Enschede

Roermond

Sittard

The Hague

Chiclayo

Lima

Lisbon

Porto

Santa Maria da Feira

Santarém

Elche

Barcelona

Madrid

Santa Cruz de Tenerife

Zaragoza

Linköping

Lund

Malmo

Stockholm

Umeå

Taoyuan District

Yungkang City

Tainan City

Taipei

Bristol

Hull

Acton

Northwood

Belfast

Manchester

Valencia

Estado Aragua

Caracas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY